{"gao_id": "GAO-21-207", "published": "2020-11-17T12:00:00Z", "released": "2020-11-17T07:00:00Z", "summary": "The federal government, in concert with private industry, has greatly accelerated efforts to develop vaccines and therapeutics for COVID-19 through Operation Warp Speed. This partnership is spending more than $10 billion on 6 vaccine candidates. In a separate effort to speed access to medical products, the Food and Drug Administration has so far issued four emergency use authorizations, referred to as EUAs, that temporarily allow...", "title": "COVID-19: Federal Efforts Accelerate Vaccine and Therapeutic Development, but More Transparency Needed on Emergency Use Authorizations", "topics": ["Medical research", "pandemics", "Safety", "Medical products", "Health Care", "Program evaluation", "Public health", "Deaths", "Public health emergencies", "Preventive health care services", "Biomedical research", "Vaccinations", "Program transparency", "Immunizations", "Federal funds", "Mortality", "Clinical trials", "Compliance oversight", "Disease control", "Research and development", "Health care", "Drugs", "Monitoring"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-21-207", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-21-207-highlights.pdf"}, {"title": "Full Report (51 pages)", "url": "https://www.gao.gov/assets/gao-21-207.pdf"}, {"title": "Accessible PDF (57 pages)", "url": "https://www.gao.gov/assets/720/710831.pdf"}]}